Overall rank by patents
#7,040
Across all tracked assignees
USPTO PatentsView assignee record - 47 granted patents across 21 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).
The verdict
Microban holds 47 US patents across 21 technology areas, rank #7,040 of 50,000 tracked assignees.
Microban Products Company has been granted 47 US utility patents between 2016 and 2025, placing Microban Products Company at rank #7,040 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.8 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a US Corporation, Microban Products Company is one of the more focused assignees in the PatentsView dataset. By volume, Microban sits between Lenovo Global Technology (united States) Inc. (47 patents, rank #7,036) and Maxar Space Llc (47 patents, rank #7,044) - the closest US assignees by grant volume. The composite Innovation Score of 45.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 36 grants, compared with 11 in the 2015–2019 window, a +227% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Microban Products Company's 11.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Microban Products Company against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Lenovo Global Technology (United States) Inc.
47 patents
Linear Labs, Inc.
47 patents
Longyear TM, Inc.
47 patents
MGC FILSHEET CO., LTD.
47 patents
MTS SYSTEMS CORPORATION
47 patents
Make Great Sales Limited
47 patents
Marchesini Group S.P.A.
47 patents
Maxar Space LLC
47 patents
MICROBAN PRODUCTS COMPANY
47 patents
What this shows Microban holds 47 patents at rank #7,040, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #7,040 in granted patent volume.
Other assignees with the most granted patents in Microban's primary technology class.
Microban's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
45 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 6.4% |
| 2017 | 1 | 2.1% |
| 2018 | 5 | 10.6% |
| 2019 | 2 | 4.3% |
| 2020 | 5 | 10.6% |
| 2021 | 6 | 12.8% |
| 2022 | 2 | 4.3% |
| 2023 | 6 | 12.8% |
| 2024 | 9 | 19.1% |
| 2025 | 8 | 17.0% |
Top 15 of 21 technology areas
Overall rank by patents
#7,040
Across all tracked assignees
45.4 out of 100
How to use this portfolio
Microban's 47 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.